Julie D. Milia
Toulouse, 31059, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Journal: Respiratory medicine and research
Published: March 10, 2022
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1.
Journal: Biomarker research
Published: July 17, 2019
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Journal: Current treatment options in oncology
Published: June 07, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 25, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 07, 2018
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 06, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 13, 2018
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 28, 2017
Toxicity of immune checkpoints inhibitors
Journal: Revue des maladies respiratoires
Published: March 31, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Journal: The European respiratory journal
Published: January 10, 2017
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.
Journal: EMBO molecular medicine
Published: December 23, 2016
Management of non-small cell lung cancer patients harboring activating mutations and CNS progression
Management of non-small cell lung cancer patients harboring activating mutations and CNS progression
Journal: Revue des maladies respiratoires
Published: December 12, 2016
Last Updated: 09/26/2026